June 3-7, 2019

Dendrogenix is selected for the InvestHorizon Accelerator, Paris, France

Only 25 companies have been selected.

InvestHorizon fosters the investment readiness of Europe’s ambitious high-tech companies. The Investment Accelerator fast tracks the fund-raising efforts and investment relations for selected companies. InvestHorizon is financed and promoted by the European Commission in association with Eureka and delivered by a consortium, coordinated by Tech Tour of which BPI and EBN is a key part.


February 9-13, 2019

Meet Dendrogenix at the ARO MidWinter Meeting

in Baltimore, USA

If you want to meet us, please send an email to Dr. Nicolas Caron :



November 10, 2018


Several specialized international business angels have participated in this round, which will allow the company’s deafness technology to reach the clinical proof of concept phase.

Dendrogenix a company developing a innovative therapies, today announces a first funding round of €3.6M, including €1.2M in capital and €2.4M in grants and recoverable advances from walloon region..